Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD) in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for clinical evaluation of the risk of CVD in these patients. The systemic inflammatory markers C-reactive protein (CRP)...
Saved in:
Main Authors: | Sirje Kaur (Author), Külli Kingo (Author), Mihkel Zilmer (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multicomponent Biomarker Approach Improves the Accuracy of Diagnostic Biomarkers for Psoriasis Vulgaris
by: Ene Reimann, et al.
Published: (2019) -
Metabolomic Analysis of Skin Biopsies from Patients with Atopic Dermatitis Reveals Hallmarks of Inflammation, Disrupted Barrier Function and Oxidative Stress
by: Liis Ilves, et al.
Published: (2021) -
Early Biomarkers of Renal Damage in Relation to Arterial Stiffness and Inflammation in Male Coronary Artery Disease Patients
by: Kaido Paapstel, et al.
Published: (2016) -
Polymorphisms in IL36G gene are associated with plaque psoriasis
by: Tanel Traks, et al.
Published: (2019) -
Neutrophil‐to‐lymphocyte ratio as a cardiovascular risk biomarker in psoriasis: A comprehensive review
by: Leopoldo Fernández Domper, et al.
Published: (2022)